Key stats
About SELECTRA J. LAMARCK BIOTECH CLASS D
Expense ratio
3.36%
Home page
Inception date
Jan 24, 2011
ISIN
LU1246176264
The main objective of this Sub-Fund is to profit from increasing share prices in the biotechnology sector. The focus is on mature top tier pharmaceutical biotech companies and companies with interesting pipeline of products in development in a single or numerous markets, like Nasdaq or NYSE.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region